Latest Therapeutic Goods Administration News | Page 16

New Covid vaccines for eligible Australians
ATAGI recommendations on use of Pfizer bivalent Covid vaccine
ATAGI recommendations on use of Pfizer Covid vaccine for children aged 6 months to 4 years
Ozempic shortage update
Should you really use your smartwatch or fitness wearable to monitor your heart?
Zimbabwe is first country in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
First immunotherapy for advanced cutaneous squamous cell carcinoma – LIBTAYO
AMA considers paracetamol rescheduling
What AMA Securing Telehealth for COVID Patients means to you
Clinical trial will test drug treatment for dementia
Zimbabwe is first county in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
Top health experts call for tobacco free WA by 2030
TEQSA Needs To Provider Greater Accountability To Higher Education Sector
International consultation on medicines and biologicals
Industry responds to proposed regulatory changes for clinical trials of medical devices
Nine broadcast of Covid vaccine phone conversation breaches licence condition
Here’s another type of COVID test to get your head around
‘Indian Viagra’ – herbal drug Kamini contains morphine and can quickly lead to dependence
Many parents use melatonin gummies to help children sleep
Western Australia restricts sale of nitrous oxide gas canisters
TGA provisionally approves Pfizer’s Covid vaccine for children aged 6 months to 5 years old
TGA is considering paracetamol restrictions due to poisonings – but what does that mean for consumers?
Athlete-informed approach drives drop in supplement positives
Treatment offers new hope for lupus – and maybe for other autoimmune diseases too
ATAGI update following Covid meeting
ATAGI statement on use of Moderna bivalent Original/Omicron vaccine
Australia’s first bivalent Covid vaccine to join rollout
Women’s Health Week: Breaking down barriers to abortion access in Australia
Imfinzi plus chemotherapy approved in US as first immunotherapy regimen for patients with advanced biliary tract cancer
ATAGI update following weekly Covid meeting 2 September
Study to investigate public perceptions of cannabidiol use
First Omicron-adapted Covid boosters are coming
New study to find COVID-fighting properties in existing medications
TGA provisionally approves Moderna bivalent Covid vaccine for use as booster dose in adults
ATAGI update following weekly Covid meeting 26 August
Novavax vaccine for adolescents aged 12
Proposed regulatory changes for clinical trials of medical devices
Shortage of tenecteplase 25 August
Positions vacant on key TGA statutory advisory committees
Doughbot Enterprises and Officer fined $87,312 and company and its Director undertake to comply with advertising rules for nicotine
TGA participates in global operation tackling illicit and counterfeit therapeutic goods
TGA grants provisional determination for sabizabulin for treatment of Covid
NetOptAwario’s new technology transforms detection of heart arrhythmias with AI and remote monitoring
WA individual fined $2,664 for alleged unlawful importation of nicotine vaping products
Hope for ‘inoperable’ cancer patients
CSIRO opens ‘missing link’ lab to developing Australian vaccine pipeline
Enviro Tech Holdings and company officers ordered by Federal Court to pay $96,000 for unlawful importation of surgical face masks
2San Pty Ltd fined $66,600 for allegedly failing to provide ongoing evidence to support performance of its Covid rapid antigen tests